UM Calabresi Clinical Oncology Research Career Development Award

UM Calabresi 临床肿瘤学研究职业发展奖

• 批准号: 10172868
• 负责人: Alan Pollack
• 金额: $ 71.52万
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-06-29 至 2023-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10172868
• 关键词: Appointment; Award; Basic Science; Childhood; Clinical; Clinical Oncology; Clinical Oncology Supplement (K12); Clinical Research; Clinical Trials; Comprehensive Cancer Center; Cultural Diversity; Data; Education; Ensure; Faculty; Florida; Generations; Geographic Locations; Growth; Gynecologic; Head and neck structure; Hematology; Immigrant; Individual; Infrastructure; Institutes; Investigation; K-Series Research Career Programs; Knowledge; Mentored Clinical Scientist Development Program; Mentors; Mentorship; Operative Surgical Procedures; Outcome; Patient-Focused Outcomes; Patients; Population; Population Research; Population Sciences; Program Development; Radiation; Research; Research Personnel; SECTM1 gene; Subgroup; Talents; Therapy trial; Time; Training; Translating; Translational Research; Universities; anticancer research; cancer care; cancer health disparity; cancer therapy; career; career development; clinical practice; design; ethnic minority population; experience; improved; novel; oncology program; patient oriented; programs; racial and ethnic; urologic

PROJECT SUMMARY The University of Miami (UM) Calabresi Clinical Oncology Research Career Development program is designed to launch the careers of clinical researchers committed to pursuing patient-oriented cancer research. Identifying such individuals and facilitating their career development will ensure that a new generation of clinician scholars can effectively translate scientific discovery to clinical research opportunities that improve the delivery of cancer care and accordingly, patient outcomes. As of recent, the University of Miami Sylvester Comprehensive Cancer Center has experienced substantial growth in its basic, translational and population science programs and has necessary infrastructure to support a successful K12 Program. UM has an outstanding cadre of Translational and Clinical Mentors, as well as, a large pool of strong and remarkably diverse potential K12 scholars to launch the proposed career development program. those radiation, faculty and University's practicums such of Scholars will include who recently completed postgraduate training in a subspecialty oncology program (pediatric, urologic, surgical, hematology, head and neck, gynecologic) and those who have recently assumed their first appointment. Scholars will choose a mentoring dyad composed of a Translational and a Clinical Mentor, will have the option of obtaining a Masters in Clinical and Translational Investigation, supported by our Clinical Translational Science Institute. Scholars will choose from a wide range of courses and designed to assist them in translating research discoveries into clinical practice. They will then use knowledge to design, implement and manage a clinical cancer therapy trial , which draws from the findings ongoing translational and population-based research initiatives led by K12 mentors.The UM K12 Program will fulfill the major objectives of the Calabresi Award. It will provide, for a two-year period, dedicated time, optimal mentorship, formal education, and practical experience in developing novel, patient centric clinical trials to a diverse group of talented, and highly-motivated clinical Scholars. The Program will evaluate short and long-term outcomes of scholars' professional trajectory and use corresponding data to adjust the program to appropriately meet the dynamic and rapidly changing landscape of clinical oncology research. An important feature of the UM K12 Program is its geographic location in South Florida, which is characterized by unparalleled multiculturalism. Such diversity provides a unique opportunity to develop trials responsive to the unique needs of racial/ethnic minorities, recent immigrants, and other population sub-groups, who contribute to cancer disparity.

项目摘要 迈阿密大学（UM）卡拉布雷西临床肿瘤学研究职业发展计划旨在 启动致力于追求以患者为导向的癌症研究的临床研究人员的职业生涯。 识别这些人并促进他们的职业发展将确保新一代 临床医生学者可以有效地将科学发现转化为临床研究机会， 提供癌症护理以及相应的患者结果。最近，迈阿密大学西尔维斯特 综合癌症中心经历了其基本，翻译和人口的大幅增长 科学计划，并有必要的基础设施，以支持一个成功的K12计划。UM有一个 优秀的翻译和临床导师骨干，以及一个强大的，卓越的 不同的潜在K12学者推出拟议的职业发展计划。 那些 辐射， 教师 和 大学 实习 等 的 学者将包括 他最近完成了亚专业肿瘤学项目（儿科，泌尿科， 外科、血液学、头颈部、妇科）以及最近首次接受 预约学者将选择由翻译和临床导师组成的指导二人组， 将有获得临床和转化研究硕士学位的选择，由我们的支持 临床转化科学研究所。学者将从广泛的课程中选择， 旨在帮助他们将研究发现转化为临床实践。然后他们将使用 设计，实施和管理临床癌症治疗试验的知识，该试验从研究结果中得出 由K12导师领导的持续转化和基于人口的研究计划。UM K12计划 将实现卡拉布雷西奖的主要目标。它将在两年期间提供专门的时间， 最佳的指导，正规教育和实践经验，开发新的，以患者为中心的临床试验 一群才华横溢、积极进取的临床学者。该计划将评估短期和 学者的专业轨迹的长期结果，并使用相应的数据来调整程序， 适当地满足临床肿瘤学研究的动态和快速变化的景观。一个重要 UM K12项目的特点是其位于南佛罗里达的地理位置，其特点是 无与伦比的多元文化这种多样性提供了一个独特的机会，以发展试验， 少数种族/族裔、新移民和其他人口亚群体的独特需求， 癌症差异